Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.270244947933086e-38,inf,inf,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.6779143355758887e-35,0,0,61
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.037288709926845e-16,32.538081107814044,1162.598530942238,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",2.7487462824837946e-14,0,0,32
3,Nonalcoholic fatty liver disease WP4396,1.6816909981444084e-12,16.849266862170087,456.80420234358996,"['NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS', 'BAX']",1.0146202355471265e-10,0,0,28
4,Mitochondrial complex I assembly model OXPHOS system WP4324,9.834624667023799e-08,inf,inf,"['NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFS6', 'NDUFB11', 'NDUFB5', 'NDUFS5', 'NDUFB3', 'NDUFB2', 'NDUFA1']",4.450167661828269e-06,0,0,12
5,Oxidative phosphorylation WP623,1.946712613245215e-06,13.513615023474179,177.69550299966207,"['ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",7.04709965994768e-05,0,0,14
6,Mitochondrial CIV Assembly WP4922,5.206608032437744e-06,17.294117647058822,210.39300572447027,"['COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX14', 'COX5B', 'COX7C', 'PET117', 'COX6B1']",0.00015706600897853862,0,0,12
7,Pyrimidine metabolism WP4022,2.2013247631507785e-05,inf,inf,"['NT5C', 'POLE4', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'POLR2K', 'POLR2L']",0.0005691996887575584,0,0,8
8,Mitochondrial complex III assembly WP4921,8.470953042505858e-05,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.0019165531258669502,0,0,7
9,Acute viral myocarditis WP4298,0.004768327639217693,inf,inf,"['ENDOG', 'CD80', 'CYCS', 'BAX']",0.09589636696648915,0,0,4
10,DNA Repair Pathways Full Network WP4946,0.016066199896319324,7.0673076923076925,29.195313801416685,"['POLE4', 'POLD4', 'NEIL2', 'CENPX', 'POLE3']",0.2625168115993249,0,0,5
11,mRNA Processing WP411,0.018200528693815703,inf,inf,"['LSM7', 'SNRPE', 'LSM2']",0.2625168115993249,0,0,3
12,Nanomaterial induced apoptosis WP2507,0.018200528693815703,inf,inf,"['ENDOG', 'BAX', 'CYCS']",0.2625168115993249,0,0,3
13,Base Excision Repair WP4752,0.018854798623155932,11.287671232876713,44.823205079190274,"['POLE4', 'POLD4', 'NEIL2', 'POLE3']",0.2625168115993249,0,0,4
14,DNA Mismatch Repair WP531,0.058497210118350094,8.442622950819672,23.96671723484543,"['POLE4', 'POLD4', 'POLE3']",0.7058663354280911,0,0,3
15,Nucleotide Excision Repair WP4753,0.058497210118350094,8.442622950819672,23.96671723484543,"['POLE4', 'POLD4', 'POLE3']",0.7058663354280911,0,0,3
16,Selenium Micronutrient Network WP15,0.06771764406715265,2.8236914600550964,7.602530921308241,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOH', 'MSRB1']",0.7660558485096643,0,0,6
17,Proteasome Degradation WP183,0.1179608758774276,4.217213114754099,9.013880883939981,"['PSMB6', 'H2AFZ', 'PSMB10']",0.900120530640293,0,0,3
18,CAMKK2  Pathway WP4874,0.17159173237408545,5.613079019073569,9.89382229378181,"['FIS1', 'MAP1LC3A']",0.900120530640293,0,0,2
19,Cytosolic DNA-sensing pathway WP4655,0.17159173237408545,5.613079019073569,9.89382229378181,"['POLR2K', 'POLR2L']",0.900120530640293,0,0,2
20,Nucleotide metabolism WP404,0.17159173237408545,5.613079019073569,9.89382229378181,"['NME2', 'OAZ1']",0.900120530640293,0,0,2
21,Eukaryotic Transcription Initiation WP405,0.17159173237408545,5.613079019073569,9.89382229378181,"['POLR2I', 'POLR2K']",0.900120530640293,0,0,2
22,Apoptosis Modulation and Signaling WP1772,0.19106499623082723,2.808743169398907,4.648867703890836,"['ENDOG', 'CYCS', 'BAX']",0.900120530640293,0,0,3
23,Ferroptosis WP4313,0.19106499623082723,2.808743169398907,4.648867703890836,"['MAP1LC3A', 'GPX4', 'FTH1']",0.900120530640293,0,0,3
24,Senescence and Autophagy in Cancer WP615,0.19134236415339625,2.248767123287671,3.7187658922421765,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3A', 'GABARAP']",0.900120530640293,0,0,4
25,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.2635712051046162,inf,inf,['SUPT4H1'],0.900120530640293,0,0,1
26,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.2635712051046162,inf,inf,['CD80'],0.900120530640293,0,0,1
27,Apoptosis Modulation by HSP70 WP384,0.2635712051046162,inf,inf,['CYCS'],0.900120530640293,0,0,1
28,Joubert Syndrome WP4656,0.2635712051046162,inf,inf,['TMEM17'],0.900120530640293,0,0,1
29,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.2635712051046162,inf,inf,['IDH3B'],0.900120530640293,0,0,1
30,Biomarkers for pyrimidine metabolism disorders WP4584,0.2635712051046162,inf,inf,['NT5C'],0.900120530640293,0,0,1
31,Tgif disruption of Shh signaling WP3674,0.2635712051046162,inf,inf,['NODAL'],0.900120530640293,0,0,1
32,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.2635712051046162,inf,inf,['BAX'],0.900120530640293,0,0,1
33,Cancer immunotherapy by CTLA4 blockade WP4582,0.2635712051046162,inf,inf,['CD80'],0.900120530640293,0,0,1
34,Cellular Proteostasis WP4918,0.2635712051046162,inf,inf,['PFDN5'],0.900120530640293,0,0,1
35,Mitochondrial CII Assembly WP4920,0.2635712051046162,inf,inf,['SDHAF1'],0.900120530640293,0,0,1
36,MTHFR deficiency WP4288,0.2635712051046162,inf,inf,['CYCS'],0.900120530640293,0,0,1
37,Nanoparticle triggered autophagic cell death WP2509,0.2635712051046162,inf,inf,['MAP1LC3A'],0.900120530640293,0,0,1
38,DNA IR-double strand breaks and cellular response via ATM WP3959,0.2635712051046162,inf,inf,['BAX'],0.900120530640293,0,0,1
39,Nephrogenesis WP5052,0.2635712051046162,inf,inf,['PAX2'],0.900120530640293,0,0,1
40,NOTCH1 regulation of endothelial cell calcification WP3413,0.2635712051046162,inf,inf,['DLL3'],0.900120530640293,0,0,1
41,One-carbon metabolism and related pathways WP3940,0.2635712051046162,inf,inf,['GPX4'],0.900120530640293,0,0,1
42,FOXP3 in COVID-19 WP5063,0.2635712051046162,inf,inf,['CD80'],0.900120530640293,0,0,1
43,Peroxiredoxin 2 induced ovarian failure WP4873,0.2635712051046162,inf,inf,['BAX'],0.900120530640293,0,0,1
44,Gastric Cancer Network 2 WP2363,0.2635712051046162,inf,inf,['S100A6'],0.900120530640293,0,0,1
45,Glutathione metabolism WP100,0.2635712051046162,inf,inf,['GPX4'],0.900120530640293,0,0,1
46,Pyrimidine metabolism and related diseases WP4225,0.2635712051046162,inf,inf,['NT5C'],0.900120530640293,0,0,1
47,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2635712051046162,inf,inf,['FGF1'],0.900120530640293,0,0,1
48,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2635712051046162,inf,inf,['BAX'],0.900120530640293,0,0,1
49,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.2635712051046162,inf,inf,['ANAPC11'],0.900120530640293,0,0,1
50,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2635712051046162,inf,inf,['ELOB'],0.900120530640293,0,0,1
51,Homologous recombination WP186,0.2635712051046162,inf,inf,['POLD4'],0.900120530640293,0,0,1
52,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2635712051046162,inf,inf,['BAX'],0.900120530640293,0,0,1
53,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2635712051046162,inf,inf,['MAP1LC3A'],0.900120530640293,0,0,1
54,Serotonin and anxiety WP3947,0.28468624106858187,2.803814713896458,3.522622001326189,"['POMC', 'CRH']",0.9201466005966664,0,0,2
55,7q11.23 copy number variation syndrome WP4932,0.28468624106858187,2.803814713896458,3.522622001326189,"['ATP5F1E', 'ATP5MC1']",0.9201466005966664,0,0,2
56,Apoptosis WP254,0.28468624106858187,2.803814713896458,3.522622001326189,"['CYCS', 'BAX']",0.9201466005966664,0,0,2
57,Alzheimer's disease WP2059,0.3958364442232502,1.8673932788374206,1.730614513200932,"['ATP5MD', 'CYCS']",0.9821912179917973,0,0,2
58,Cardiac Progenitor Differentiation WP2406,0.3958364442232502,1.8673932788374206,1.730614513200932,"['MESP1', 'NODAL']",0.9821912179917973,0,0,2
59,Modulators of TCR signaling and T cell activation WP5072,0.3958364442232502,1.8673932788374206,1.730614513200932,"['NDUFB10', 'ELOB']",0.9821912179917973,0,0,2
60,Differentiation Pathway WP2848,0.3958364442232502,1.8673932788374206,1.730614513200932,"['FGF1', 'NODAL']",0.9821912179917973,0,0,2
61,Regulation of Actin Cytoskeleton WP51,0.4374240156621006,1.400273224043716,1.1578190893768086,"['TMSB4X', 'BRK1', 'FGF1']",0.9821912179917973,0,0,3
62,ID signaling pathway WP53,0.4578113011746912,2.7989130434782608,2.186785683458283,['PAX2'],0.9821912179917973,0,0,1
63,AGE/RAGE pathway WP2324,0.4578113011746912,2.7989130434782608,2.186785683458283,['CYCS'],0.9821912179917973,0,0,1
64,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4578113011746912,2.7989130434782608,2.186785683458283,['DLL3'],0.9821912179917973,0,0,1
65,Iron metabolism in placenta WP2007,0.4578113011746912,2.7989130434782608,2.186785683458283,['FTH1'],0.9821912179917973,0,0,1
66,Type 2 papillary renal cell carcinoma WP4241,0.4578113011746912,2.7989130434782608,2.186785683458283,['ELOB'],0.9821912179917973,0,0,1
67,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4578113011746912,2.7989130434782608,2.186785683458283,['BAX'],0.9821912179917973,0,0,1
68,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4578113011746912,2.7989130434782608,2.186785683458283,['CD80'],0.9821912179917973,0,0,1
69,DNA Replication WP466,0.4578113011746912,2.7989130434782608,2.186785683458283,['POLD4'],0.9821912179917973,0,0,1
70,Dual hijack model of Vif in HIV infection WP3300,0.4578113011746912,2.7989130434782608,2.186785683458283,['ELOB'],0.9821912179917973,0,0,1
71,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4578113011746912,2.7989130434782608,2.186785683458283,['MAP1LC3A'],0.9821912179917973,0,0,1
72,Notch Signaling WP268,0.4578113011746912,2.7989130434782608,2.186785683458283,['DLL3'],0.9821912179917973,0,0,1
73,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.4578113011746912,2.7989130434782608,2.186785683458283,['CD63'],0.9821912179917973,0,0,1
74,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.4578113011746912,2.7989130434782608,2.186785683458283,['MAP1LC3A'],0.9821912179917973,0,0,1
75,Parkinson's disease pathway WP2371,0.4578113011746912,2.7989130434782608,2.186785683458283,['CYCS'],0.9821912179917973,0,0,1
76,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4578113011746912,2.7989130434782608,2.186785683458283,['CD80'],0.9821912179917973,0,0,1
77,GDNF/RET signaling axis WP4830,0.4578113011746912,2.7989130434782608,2.186785683458283,['PAX2'],0.9821912179917973,0,0,1
78,Genes related to primary cilium development (based on CRISPR) WP4536,0.4578113011746912,2.7989130434782608,2.186785683458283,['TMEM17'],0.9821912179917973,0,0,1
79,Genes targeted by miRNAs in adipocytes WP1992,0.4578113011746912,2.7989130434782608,2.186785683458283,['TMSB4X'],0.9821912179917973,0,0,1
80,Purine metabolism WP4792,0.4578113011746912,2.7989130434782608,2.186785683458283,['APRT'],0.9821912179917973,0,0,1
81,Glycosylation and related congenital defects WP4521,0.4578113011746912,2.7989130434782608,2.186785683458283,['DPM3'],0.9821912179917973,0,0,1
82,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.4578113011746912,2.7989130434782608,2.186785683458283,['BAX'],0.9821912179917973,0,0,1
83,miRNA regulation of DNA damage response WP1530,0.49822211220970564,1.3991825613079019,0.974823492977862,"['CYCS', 'BAX']",0.9821912179917973,0,0,2
84,Copper homeostasis WP3286,0.49822211220970564,1.3991825613079019,0.974823492977862,"['COX17', 'ATOX1']",0.9821912179917973,0,0,2
85,DNA damage response WP707,0.49822211220970564,1.3991825613079019,0.974823492977862,"['CYCS', 'BAX']",0.9821912179917973,0,0,2
86,Non-small cell lung cancer WP4255,0.49822211220970564,1.3991825613079019,0.974823492977862,"['CYCS', 'BAX']",0.9821912179917973,0,0,2
87,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.49822211220970564,1.3991825613079019,0.974823492977862,"['PGK1', 'BAX']",0.9821912179917973,0,0,2
88,Integrated breast cancer pathway WP1984,0.5887386704298426,1.1182561307901908,0.5924217679312241,"['BAX', 'FAU']",0.9821912179917973,0,0,2
89,Mesodermal commitment pathway WP2857,0.5887386704298426,1.1182561307901908,0.5924217679312241,"['RPL38', 'NODAL']",0.9821912179917973,0,0,2
90,Osteoblast differentiation WP4787,0.5887386704298426,1.1182561307901908,0.5924217679312241,"['FGF1', 'DLL3']",0.9821912179917973,0,0,2
91,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5887386704298426,1.1182561307901908,0.5924217679312241,"['CD80', 'PAX2']",0.9821912179917973,0,0,2
92,16p11.2 distal deletion syndrome WP4950,0.600920946291236,1.3980978260869565,0.712039884324987,['SLN'],0.9821912179917973,0,0,1
93,Serotonin and anxiety-related events WP3944,0.600920946291236,1.3980978260869565,0.712039884324987,['CRH'],0.9821912179917973,0,0,1
94,Integrated Cancer Pathway WP1971,0.600920946291236,1.3980978260869565,0.712039884324987,['BAX'],0.9821912179917973,0,0,1
95,TP53 network WP1742,0.600920946291236,1.3980978260869565,0.712039884324987,['BAX'],0.9821912179917973,0,0,1
96,Translation Factors WP107,0.600920946291236,1.3980978260869565,0.712039884324987,['EEF1B2'],0.9821912179917973,0,0,1
97,Vitamin D-sensitive calcium signaling in depression WP4698,0.600920946291236,1.3980978260869565,0.712039884324987,['GPX4'],0.9821912179917973,0,0,1
98,Development of ureteric collection system WP5053,0.600920946291236,1.3980978260869565,0.712039884324987,['PAX2'],0.9821912179917973,0,0,1
99,NO/cGMP/PKG mediated Neuroprotection WP4008,0.600920946291236,1.3980978260869565,0.712039884324987,['CYCS'],0.9821912179917973,0,0,1
100,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.600920946291236,1.3980978260869565,0.712039884324987,['BAX'],0.9821912179917973,0,0,1
101,Overview of nanoparticle effects WP3287,0.600920946291236,1.3980978260869565,0.712039884324987,['BAX'],0.9821912179917973,0,0,1
102,Fas ligand pathway and stress induction of heat shock proteins WP314,0.600920946291236,1.3980978260869565,0.712039884324987,['CYCS'],0.9821912179917973,0,0,1
103,Fatty acid transporters WP5061,0.600920946291236,1.3980978260869565,0.712039884324987,['FABP6'],0.9821912179917973,0,0,1
104,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.600920946291236,1.3980978260869565,0.712039884324987,['H2AFZ'],0.9821912179917973,0,0,1
105,Genes controlling nephrogenesis WP4823,0.600920946291236,1.3980978260869565,0.712039884324987,['PAX2'],0.9821912179917973,0,0,1
106,Glycolysis in senescence WP5049,0.600920946291236,1.3980978260869565,0.712039884324987,['PGK1'],0.9821912179917973,0,0,1
107,Purine metabolism and related disorders WP4224,0.600920946291236,1.3980978260869565,0.712039884324987,['APRT'],0.9821912179917973,0,0,1
108,Retinoblastoma gene in cancer WP2446,0.600920946291236,1.3980978260869565,0.712039884324987,['H2AFZ'],0.9821912179917973,0,0,1
109,Androgen receptor signaling pathway WP138,0.6665192152851155,0.9309718437783833,0.3776825316846873,"['BAG1', 'STUB1']",0.9821912179917973,0,0,2
110,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6665192152851155,0.9309718437783833,0.3776825316846873,"['CYCS', 'BAX']",0.9821912179917973,0,0,2
111,Endometrial cancer WP4155,0.6665192152851155,0.9309718437783833,0.3776825316846873,"['BAX', 'FGF1']",0.9821912179917973,0,0,2
112,Genotoxicity pathway WP4286,0.6665192152851155,0.9309718437783833,0.3776825316846873,"['RPS27', 'TRIAP1']",0.9821912179917973,0,0,2
113,VEGFA-VEGFR2 Signaling Pathway WP3888,0.7050021667656741,0.8696030640668524,0.30397357968780925,"['SET', 'RPL18A', 'TMSB4X', 'PGK1', 'CYCS', 'RPLP2', 'RPL26', 'RPL10A', 'TMSB10', 'RPL7']",0.9821912179917973,0,0,10
114,Amyotrophic lateral sclerosis (ALS) WP2447,0.706332391944364,0.9311594202898551,0.3237355831035767,['BAX'],0.9821912179917973,0,0,1
115,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.706332391944364,0.9311594202898551,0.3237355831035767,['POMC'],0.9821912179917973,0,0,1
116,Toll-like Receptor Signaling Pathway WP75,0.706332391944364,0.9311594202898551,0.3237355831035767,['CD80'],0.9821912179917973,0,0,1
117,Canonical and non-canonical Notch signaling WP3845,0.706332391944364,0.9311594202898551,0.3237355831035767,['DLL3'],0.9821912179917973,0,0,1
118,MET in type 1 papillary renal cell carcinoma WP4205,0.706332391944364,0.9311594202898551,0.3237355831035767,['RPL11'],0.9821912179917973,0,0,1
119,Metabolic reprogramming in colon cancer WP4290,0.706332391944364,0.9311594202898551,0.3237355831035767,['PGK1'],0.9821912179917973,0,0,1
120,Computational Model of Aerobic Glycolysis WP4629,0.706332391944364,0.9311594202898551,0.3237355831035767,['PGK1'],0.9821912179917973,0,0,1
121,DNA damage response (only ATM dependent) WP710,0.706332391944364,0.9311594202898551,0.3237355831035767,['BAX'],0.9821912179917973,0,0,1
122,Nephrotic syndrome WP4758,0.706332391944364,0.9311594202898551,0.3237355831035767,['PAX2'],0.9821912179917973,0,0,1
123,Ectoderm Differentiation WP2858,0.706332391944364,0.9311594202898551,0.3237355831035767,['LY6E'],0.9821912179917973,0,0,1
124,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.706332391944364,0.9311594202898551,0.3237355831035767,['IFI27L2'],0.9821912179917973,0,0,1
125,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.706332391944364,0.9311594202898551,0.3237355831035767,['MAP1LC3A'],0.9821912179917973,0,0,1
126,Galanin receptor pathway WP4970,0.706332391944364,0.9311594202898551,0.3237355831035767,['POMC'],0.9821912179917973,0,0,1
127,Regulation of Microtubule Cytoskeleton WP2038,0.706332391944364,0.9311594202898551,0.3237355831035767,['PARD6A'],0.9821912179917973,0,0,1
128,Histone Modifications WP2369,0.706332391944364,0.9311594202898551,0.3237355831035767,['SET'],0.9821912179917973,0,0,1
129,22q11.2 copy number variation syndrome WP4657,0.7080408452593098,0.8368852459016394,0.2889375568215838,"['RANBP1', 'MRPL40', 'THAP7']",0.9821912179917973,0,0,3
130,Sleep regulation WP3591,0.7319749104091272,0.7971973530556636,0.24873278161910636,"['CRH', 'HCRTR1']",0.9821912179917973,0,0,2
131,Inflammatory Response Pathway WP453,0.7839562616382055,0.6976902173913043,0.16981922842082553,['CD80'],0.9821912179917973,0,0,1
132,Lung fibrosis WP3624,0.7839562616382055,0.6976902173913043,0.16981922842082553,['FGF1'],0.9821912179917973,0,0,1
133,Cori Cycle WP1946,0.7839562616382055,0.6976902173913043,0.16981922842082553,['PGK1'],0.9821912179917973,0,0,1
134,Notch Signaling Pathway Netpath WP61,0.7839562616382055,0.6976902173913043,0.16981922842082553,['DLL3'],0.9821912179917973,0,0,1
135,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7839562616382055,0.6976902173913043,0.16981922842082553,['NDUFA13'],0.9821912179917973,0,0,1
136,p53 transcriptional gene network WP4963,0.7839562616382055,0.6976902173913043,0.16981922842082553,['BAX'],0.9821912179917973,0,0,1
137,Small cell lung cancer WP4658,0.7861840647757217,0.696866485013624,0.16764122245673788,"['CYCS', 'BAX']",0.9821912179917973,0,0,2
138,Corticotropin-releasing hormone signaling pathway WP2355,0.7861840647757217,0.696866485013624,0.16764122245673788,"['POMC', 'CRH']",0.9821912179917973,0,0,2
139,Breast cancer pathway WP4262,0.8000736466704557,0.6960382513661202,0.1552523740849048,"['BAX', 'FGF1', 'DLL3']",0.9821912179917973,0,0,3
140,IL-18 signaling pathway WP4754,0.8179256743774114,0.724398131512756,0.1455922957958785,"['NRN1', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'ITM2C']",0.9821912179917973,0,0,6
141,Hepatitis B infection WP4666,0.8305133530555487,0.6188313654253709,0.1149239598564959,"['CYCS', 'BAX']",0.9821912179917973,0,0,2
142,Allograft Rejection WP2328,0.8411029767333071,0.5576086956521739,0.09648926718937233,['CD80'],0.9821912179917973,0,0,1
143,Aryl Hydrocarbon Receptor Pathway WP2873,0.8411029767333071,0.5576086956521739,0.09648926718937233,['BAX'],0.9821912179917973,0,0,1
144,Leptin signaling pathway WP2034,0.8411029767333071,0.5576086956521739,0.09648926718937233,['BAX'],0.9821912179917973,0,0,1
145,TNF-alpha signaling pathway WP231,0.8411029767333071,0.5576086956521739,0.09648926718937233,['BAX'],0.9821912179917973,0,0,1
146,Ciliopathies WP4803,0.8411029767333071,0.5576086956521739,0.09648926718937233,['TMEM17'],0.9821912179917973,0,0,1
147,Neural Crest Differentiation WP2064,0.8411029767333071,0.5576086956521739,0.09648926718937233,['DLL3'],0.9821912179917973,0,0,1
148,ESC Pluripotency Pathways WP3931,0.8411029767333071,0.5576086956521739,0.09648926718937233,['FGF1'],0.9821912179917973,0,0,1
149,Oxidative Damage WP3941,0.8411029767333071,0.5576086956521739,0.09648926718937233,['CYCS'],0.9821912179917973,0,0,1
150,Pancreatic adenocarcinoma pathway WP4263,0.8411029767333071,0.5576086956521739,0.09648926718937233,['BAX'],0.9821912179917973,0,0,1
151,Folate Metabolism WP176,0.8411029767333071,0.5576086956521739,0.09648926718937233,['GPX4'],0.9821912179917973,0,0,1
152,PPAR signaling pathway WP3942,0.8411029767333071,0.5576086956521739,0.09648926718937233,['FABP6'],0.9821912179917973,0,0,1
153,Prostaglandin Synthesis and Regulation WP98,0.8411029767333071,0.5576086956521739,0.09648926718937233,['S100A6'],0.9821912179917973,0,0,1
154,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8411029767333071,0.5576086956521739,0.09648926718937233,['BAX'],0.9821912179917973,0,0,1
155,Regulation of toll-like receptor signaling pathway WP1449,0.8411029767333071,0.5576086956521739,0.09648926718937233,['CD80'],0.9821912179917973,0,0,1
156,Circadian rhythm related genes WP3594,0.8717894660081351,0.6167427701674277,0.0846216240352081,"['CAVIN3', 'CRH', 'RPS27A', 'HCRTR1']",0.9990788019227522,0,0,4
157,Ciliary landscape WP4352,0.8831635818101676,0.4642210144927536,0.05767706505424706,['COPS7A'],0.9990788019227522,0,0,1
158,Endoderm differentiation WP2853,0.8831635818101676,0.4642210144927536,0.05767706505424706,['NODAL'],0.9990788019227522,0,0,1
159,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8831635818101676,0.4642210144927536,0.05767706505424706,['STUB1'],0.9990788019227522,0,0,1
160,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8831635818101676,0.4642210144927536,0.05767706505424706,['BAX'],0.9990788019227522,0,0,1
161,TGF-beta Signaling Pathway WP366,0.8951826279384484,0.5053257369333664,0.055953469665634546,"['PARD6A', 'CITED1']",0.9999612358278109,0,0,2
162,EGF/EGFR signaling pathway WP437,0.9141126673363102,0.39751552795031053,0.03569746949741864,['NDUFA13'],0.9999612358278109,0,0,1
163,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9368797811216962,0.34748641304347827,0.02265622076462482,['TMSB4X'],0.9999612358278109,0,0,1
164,Melanoma WP4685,0.9368797811216962,0.34748641304347827,0.02265622076462482,['BAX'],0.9999612358278109,0,0,1
165,Cell cycle WP179,0.9368797811216962,0.34748641304347827,0.02265622076462482,['ANAPC11'],0.9999612358278109,0,0,1
166,Pathways in clear cell renal cell carcinoma WP4018,0.9368797811216962,0.34748641304347827,0.02265622076462482,['PGK1'],0.9999612358278109,0,0,1
167,Prader-Willi and Angelman Syndrome WP3998,0.9368797811216962,0.34748641304347827,0.02265622076462482,['POMC'],0.9999612358278109,0,0,1
168,Proximal tubule transport WP4917,0.9368797811216962,0.34748641304347827,0.02265622076462482,['SLC7A9'],0.9999612358278109,0,0,1
169,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9536236483492992,0.3085748792270531,0.014653043478722406,['DLL3'],0.9999612358278109,0,0,1
170,Glycolysis and Gluconeogenesis WP534,0.9536236483492992,0.3085748792270531,0.014653043478722406,['PGK1'],0.9999612358278109,0,0,1
171,Peptide GPCRs WP24,0.9816338636433241,0.2307518115942029,0.004277420433403141,['HCRTR1'],0.9999612358278109,0,0,1
172,NRF2 pathway WP2884,0.9865194720760566,0.21279264214046822,0.002888067525262781,['FTH1'],0.9999612358278109,0,0,1
173,Complement system WP2806,0.9946771037814436,0.17238451086956522,0.0009200356663290125,['RPS19'],0.9999612358278109,0,0,1
174,Metapathway biotransformation Phase I and II WP702,0.9960966934248955,0.1620843989769821,0.0006339030656606013,['GPX4'],0.9999612358278109,0,0,1
175,Vitamin D Receptor Pathway WP2877,0.9960966934248955,0.1620843989769821,0.0006339030656606013,['S100A6'],0.9999612358278109,0,0,1
176,MAPK Signaling Pathway WP382,0.9971382597407882,0.15292874396135267,0.00043826975001059045,['FGF1'],0.9999612358278109,0,0,1
177,Myometrial relaxation and contraction pathways WP289,0.9971382597407882,0.15292874396135267,0.00043826975001059045,['CRH'],0.9999612358278109,0,0,1
178,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9979022629549947,0.14473684210526316,0.0003039387388111421,['FGF1'],0.9999612358278109,0,0,1
179,PI3K-Akt signaling pathway WP4172,0.9988732537453567,0.1306935817805383,0.00014734152763133592,['FGF1'],0.9999612358278109,0,0,1
180,Nuclear Receptors Meta-Pathway WP2882,0.999796731792505,0.15980125020035263,3.24858154622989e-05,"['FTH1', 'BAX']",0.9999612358278109,0,0,2
181,"GPCRs, Class A Rhodopsin-like WP455",0.9999612358278109,0.08483355978260869,3.2885664585144385e-06,['HCRTR1'],0.9999612358278109,0,0,1
